These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1311498)

  • 1. Focal ventricular thinning caused by indomethacin in the late phase of coxsackievirus B4 murine myocarditis.
    Khatib R; Reyes MP; Khatib G; Smith F; Rezkella S; Kloner RA
    Am J Med Sci; 1992 Feb; 303(2):95-8. PubMed ID: 1311498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of indomethacin in the late phase of coxsackievirus myocarditis in a murine model.
    Rezkalla S; Khatib R; Khatib G; Smith F; Walsh M; Sowers J; Kloner R
    J Lab Clin Med; 1988 Jul; 112(1):118-21. PubMed ID: 2839587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of subsequent myocardial damage on the expression of coxsackievirus B4 myocarditis and the development of ventricular aneurysms.
    Khatib R; Khatib G; Reyes MP; Giraldo A
    Eur Heart J; 1994 Aug; 15(8):1140-3. PubMed ID: 7988609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of coxsackievirus B4 virulence by indomethacin.
    Khatib R; Reyes MP; Smith F; Khatib G; Rezkalla S
    J Lab Clin Med; 1990 Jul; 116(1):116-20. PubMed ID: 1695914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of delayed captopril therapy on left ventricular mass and myonecrosis during acute coxsackievirus murine myocarditis.
    Rezkalla S; Kloner RA; Khatib G; Khatib R
    Am Heart J; 1990 Dec; 120(6 Pt 1):1377-81. PubMed ID: 2174203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of pre-existing coxsackievirus B4 myocardial disease on the expression of coxsackievirus B3 myocarditis.
    Khatib R; Reyes MP; Khatib G; Giraldo A
    Can J Cardiol; 1993 Jun; 9(5):444-7. PubMed ID: 8394194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of metoprolol in acute coxsackievirus B3 murine myocarditis.
    Rezkalla S; Kloner RA; Khatib G; Smith FE; Khatib R
    J Am Coll Cardiol; 1988 Aug; 12(2):412-4. PubMed ID: 2839568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial injury occurs earlier than myocardial inflammation in acute experimental viral myocarditis.
    Lim BK; Shin JO; Choe SC; Choi SW; Jeong JO; Seong IW; Kim DK; Jeon ES
    Exp Mol Med; 2005 Feb; 37(1):51-7. PubMed ID: 15761252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine and murine coxsackievirus B3 myocarditis. Interleukin-2 suppressed myocarditis in the acute stage but enhanced the condition in the subsequent stage.
    Kishimoto C; Kuroki Y; Hiraoka Y; Ochiai H; Kurokawa M; Sasayama S
    Circulation; 1994 Jun; 89(6):2836-42. PubMed ID: 8205699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coxsackievirus B4 myocarditis in mice: valvular changes in virus-infected and control animals.
    el-Khatib MR; Chason JL; Ho KL; Silberberg B; Lerner AM
    J Infect Dis; 1978 Apr; 137(4):410-20. PubMed ID: 649986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effects of captopril in acute coxsackievirus B3 murine myocarditis.
    Rezkalla S; Kloner RA; Khatib G; Khatib R
    Circulation; 1990 Mar; 81(3):1039-46. PubMed ID: 2155071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successive infection of coxsackievirus B3 and encephalomyocarditis virus: an animal model of chronic myocarditis.
    Okada I; Matsumori A; Tomioka N; Kawai C
    J Pathol; 1992 Jul; 167(3):341-7. PubMed ID: 1325552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fasudil exerts a cardio-protective effect on mice with coxsackievirus B3-induced acute viral myocarditis.
    Dai K; Wang Y; Tai S; Ni H; Lian H; Yu Y; Liao W; Zheng C; Chen Q; Kuver A; Li J
    Cardiovasc Ther; 2018 Dec; 36(6):e12477. PubMed ID: 30380183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coxsackievirus B3 murine myocarditis: deleterious effects of nonsteroidal anti-inflammatory agents.
    Rezkalla S; Khatib G; Khatib R
    J Lab Clin Med; 1986 Apr; 107(4):393-5. PubMed ID: 2420912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of levosimendan in experimental acute coxsackievirus myocarditis.
    Latva-Hirvelä J; Kytö V; Saraste A; Vuorinen T; Levijoki J; Saukko P
    Eur J Clin Invest; 2009 Oct; 39(10):876-82. PubMed ID: 19772522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppression with high doses of cyclophosphamide reduces the severity of myocarditis but increases the mortality in murine Coxsackievirus B3 myocarditis.
    Kishimoto C; Thorp KA; Abelmann WH
    Circulation; 1990 Sep; 82(3):982-9. PubMed ID: 2168299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of granulocyte colony-stimulating factor upon coxsackievirus B3 myocarditis in mice.
    Hiraoka Y; Kishimoto C; Takada H; Suzaki N; Shiraki K
    Eur Heart J; 1995 Dec; 16(12):1900-6. PubMed ID: 8682024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Virus demonstration and pathologic changes in different phases of coxsackievirus B myocarditis in mice].
    Rabausch-Starz I; Neu N; Müller-Hermelink HK
    Verh Dtsch Ges Pathol; 1990; 74():398-403. PubMed ID: 1708625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ventricular aneurysms complicating coxsackievirus group B, types 1 and 4 murine myocarditis.
    El-Khatib MR; Chason JL; Lerner AM
    Circulation; 1979 Feb; 59(2):412-6. PubMed ID: 215340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of endurance exercise training on myocardial fibrosis and arrhythmogenesis in a coxsackievirus B3 myocarditis mouse model.
    Favere K; Van Hecke M; Eens S; Bosman M; Delputte PL; De Sutter J; Fransen E; Roskams T; Guns PJ; Heidbuchel H
    Sci Rep; 2024 Jun; 14(1):12653. PubMed ID: 38825590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.